BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29286913)

  • 21. Misclassification of chronic hepatitis B natural history phase: Insight from new ALT, AST, AKP, and GGT reference intervals in Chinese children.
    Chang Y; Li H; Ren H; Xu H; Hu P
    Clin Chim Acta; 2019 Feb; 489():61-67. PubMed ID: 30503274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing the Role of Septin9 Gene Methylation in the Diagnosis and Treatment of Primary Liver Cancer in the Elderly.
    Liu H; Wei D; Yan Z; Cui B; Song Y; Yin H
    Altern Ther Health Med; 2023 May; 29(4):194-199. PubMed ID: 36947654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of gamma-glutamyltransferase in the diagnosis of chronic hepatitis B].
    Wang G; Liu M; Jiang X; Ming L; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):120-2. PubMed ID: 11983131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
    Shi X; Zhou Y; Xia L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
    Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
    PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
    Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.
    Ni RZ; Huang JF; Xiao MB; Li M; Meng XY
    World J Gastroenterol; 2003 Apr; 9(4):710-3. PubMed ID: 12679916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SERUM ALPHA FETOPROTEIN, A SURROGATE MARKER FOR LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS C.
    Sultana C; Diţă C; Botescu A; Grancea C; Ruţă S
    Roum Arch Microbiol Immunol; 2014; 73(3-4):69-73. PubMed ID: 26201121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010.
    Lee K; Yang JH
    Metab Syndr Relat Disord; 2013 Aug; 11(4):229-35. PubMed ID: 23451816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
    Bao YX; Yang Y; Zhao HR; Mao R; Xiao L; Zhang YF; Aisiker T; Wen H
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):505-8. PubMed ID: 24257301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality.
    Arndt V; Brenner H; Rothenbacher D; Zschenderlein B; Fraisse E; Fliedner TM
    Int Arch Occup Environ Health; 1998 Sep; 71(6):405-12. PubMed ID: 9766914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic architecture of liver enzyme levels: GGT, ALT and AST.
    van Beek JH; de Moor MH; de Geus EJ; Lubke GH; Vink JM; Willemsen G; Boomsma DI
    Behav Genet; 2013 Jul; 43(4):329-39. PubMed ID: 23580007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
    Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
    Omata M; Yoshida H; Toyota J; Tomita E; Nishiguchi S; Hayashi N; Iino S; Makino I; Okita K; Toda G; Tanikawa K; Kumada H;
    Gut; 2007 Dec; 56(12):1747-53. PubMed ID: 17573387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults.
    Tsai J; Ford ES; Li C; Zhao G
    Addict Behav; 2012 Jan; 37(1):78-84. PubMed ID: 21975024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.